Previous studies show that upregulation of GCNT1 correlates with higher levels of core 2 O-sLeX on PSA, PAP, and MUC1 proteins22, but how GCNT1 modifies global glycosylation in prostate cancer cells has not been studied. The gene discussed is MUC1; the disease is prostate carcinoma.